Hu N

No ORCID on file · 2 papers in corpus
2026
Translational cancer research ·doi:10.21037/tcr-2025-1-2580

BackgroundOvarian cancer is a lethal gynecological malignancy, with ~70% of patients diagnosed at advanced stages (5-year survival <30%) due to suboptimal early detection tools. Current modalities [e.g., carbohydrate antigen 125 (CA125), im…

2018
Oncotarget ·doi:10.18632/oncotarget.23274

Chronic myelocytic leukemia (CML) is characterized by increased and unregulated growth of predominantly myeloid cells in the bone marrow, and accumulation of these cells in blood. We investigated the effects of an anti-malarial drug, dihydr…